NeuroMetrix, Inc, Low Float, Lands Deal With GlaxoSmithKline
Updated
New and innovative product. Quell's proven technology is 5x more powerful on average than other over-the-counter pain relief devices. It is discreet and completely wearable to enable pain relief when your patients need it.
Increased quarterly earnings growth.
Low floater
Resistance at at 3.00 range due to the preferred shares being exercisible at 2.83
Target is 2.50. Nice day trade potential. They just had the biggest trading volume in a very long time, by a long shot.
Increased quarterly earnings growth.
Low floater
Resistance at at 3.00 range due to the preferred shares being exercisible at 2.83
Target is 2.50. Nice day trade potential. They just had the biggest trading volume in a very long time, by a long shot.
Note
buy hereNote
fold, DOW collapsing
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.